Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue ...
$PODD insiders have traded $PODD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
Insulet Corporation (NASDAQ:PODD) ranks among the best medical device stocks to invest in. Canaccord Genuity maintained its Buy rating on Insulet Corporation (NASDAQ:PODD) and boosted its price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results